This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignees: Jiangsu Nhwa Pharmaceutical Co., Ltd, Shujing Biopharma Co., Ltd. Active years: 2026.
Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2026
Title: Yongqi Wu: Innovator in Neuropsychiatric Medicaments
Introduction
Yongqi Wu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating neuropsychiatric diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Yongqi Wu holds a patent for a "Heterocyclic substituted fused γ-carboline derivative, preparation method therefor, intermediate thereof and use thereof." This invention relates to a unique compound structure that can be utilized in the preparation of medicaments for neuropsychiatric conditions. The compound is represented by a specific formula, indicating its potential therapeutic applications.
Career Highlights
Throughout his career, Yongqi Wu has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Nhwa Pharmaceutical Co., Ltd and Shujing Biopharma Co., Ltd. His experience in these organizations has contributed to his development as a leading inventor in his field.
Collaborations
Yongqi Wu has collaborated with notable professionals in the industry, including Bingcheng Zhou and Jun Qin. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in medicinal chemistry.
Conclusion
Yongqi Wu's contributions to the field of neuropsychiatric medicaments through his patented inventions highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.